Predicate selection and substantial equivalence are closely coupled in practice. When indications, claims, and evidence are aligned early, review cycles become more predictable and the rationale is easier to defend.
Regulatory teams add the most value when their time is spent on technical and clinical judgment. Internal contradictions consume that time and introduce avoidable delay.
Purpose: Evaluate process and quality effects associated with improved predicate discipline and internal consistency checks.
| Metric | Baseline | Pilot | Change |
|---|---|---|---|
| Kickoff to FDA clearance (months) | 6.8 | 4.4 | 2.4 mo |
| Indications vs claims mismatches (index) | 100 | 21 | 79% |